World Antibody-Drug Conjugate Summit, October 15–16, 2013, San Francisco, CA
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
World Antibody-Drug Conjugate Summit, October 15–16, 2013, San Francisco, CA
Authors
Keywords
-
Journal
mAbs
Volume 6, Issue 1, Pages 18-29
Publisher
Informa UK Limited
Online
2013-12-10
DOI
10.4161/mabs.27437
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hydrazino-Pictet-Spengler Ligation as a Biocompatible Method for the Generation of Stable Protein Conjugates
- (2013) Paresh Agarwal et al. BIOCONJUGATE CHEMISTRY
- Location Matters: Site of Conjugation Modulates Stability and Pharmacokinetics of Antibody Drug Conjugates
- (2013) Pavel Strop et al. CHEMISTRY & BIOLOGY
- On translation of antibody drug conjugates efficacy from mouse experimental tumors to the clinic: a PK/PD approach
- (2013) Nahor Haddish-Berhane et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Key bioanalytical measurements for antibody–drug conjugate development: PK/PD modelers’ perspective
- (2013) Dhaval K Shah et al. Bioanalysis
- Synthesis of Heterobifunctional Protein Fusions Using Copper-Free Click Chemistry and the Aldehyde Tag
- (2012) Jason E. Hudak et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- A population pharmacokinetic/pharmacodynamic model of thrombocytopenia characterizing the effect of trastuzumab emtansine (T-DM1) on platelet counts in patients with HER2-positive metastatic breast cancer
- (2012) Brendan C. Bender et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Semi-mechanistic Population Pharmacokinetic Model of Multivalent Trastuzumab Emtansine in Patients with Metastatic Breast Cancer
- (2012) V L Chudasama et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Bench to bedside translation of antibody drug conjugates using a multiscale mechanistic PK/PD model: a case study with brentuximab-vedotin
- (2012) Dhaval K. Shah et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Fourth World Antibody-Drug Conjugate Summit
- (2012) Alain Beck et al. mAbs
- Site-specific chemical protein conjugation using genetically encoded aldehyde tags
- (2012) David Rabuka et al. Nature Protocols
- Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human
- (2011) Dhaval K. Shah et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- World Antibody Drug Conjugate Summit Europe
- (2011) Alain Beck et al. mAbs
- Site-Specific and Stoichiometric Modification of Antibodies by Bacterial Transglutaminase
- (2010) Simone Jeger et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Chemoenzymatic methods for site-specific protein modification
- (2010) David Rabuka CURRENT OPINION IN CHEMICAL BIOLOGY
- Antibody-Drug Conjugates for the Treatment of Non-Hodgkin's Lymphoma: Target and Linker-Drug Selection
- (2009) A. G. Polson et al. CANCER RESEARCH
- Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
- (2009) P. Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
- (2008) Jagath R Junutula et al. NATURE BIOTECHNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started